Fresenius Medical Care AG (FRA:FMEA)
Germany · Delayed Price · Currency is EUR 18.40
+0.10 (0.55%)
Last updated: Jan 29, 2026, 8:08 AM CET
Fresenius Medical Care AG Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 718.19 | 537.91 | 499 | 673.41 | 969.31 | 1,164 |
Depreciation & Amortization | 1,442 | 1,483 | 1,556 | 1,720 | 1,585 | 1,587 |
Other Amortization | 52.7 | 52.7 | 56.49 | - | - | - |
Loss (Gain) From Sale of Assets | 131.3 | -12.17 | -12.9 | -99.27 | 44.09 | -58.36 |
Asset Writedown & Restructuring Costs | 109.07 | 206.72 | 139.23 | 118.23 | 38.31 | 199.03 |
Loss (Gain) on Equity Investments | -171.83 | -134.88 | -121.79 | -66.56 | -92.18 | -94.52 |
Other Operating Activities | 26.95 | -191.3 | -48.76 | -50.5 | 42.37 | 200.3 |
Change in Accounts Receivable | -142.32 | -73.48 | -151.84 | -46.68 | -163.2 | 71.7 |
Change in Inventory | -93.83 | 107.9 | -13.14 | -204.31 | -48.53 | -355.83 |
Change in Accounts Payable | 184.04 | 155.59 | 108.48 | -356.79 | -363.96 | 1,374 |
Change in Income Taxes | 351.97 | 482.27 | 472.08 | 325.68 | 313.71 | 324.46 |
Change in Other Net Operating Assets | -97.31 | -227.97 | 145.7 | 154.03 | 164.2 | -178.47 |
Operating Cash Flow | 2,511 | 2,386 | 2,629 | 2,167 | 2,489 | 4,233 |
Operating Cash Flow Growth | 10.45% | -9.23% | 21.29% | -12.94% | -41.19% | 64.91% |
Capital Expenditures | -733.05 | -699.36 | -684.6 | -723.99 | -854.36 | -1,052 |
Sale of Property, Plant & Equipment | 19.24 | 14.1 | 16.14 | 36.21 | 24.42 | 15.58 |
Cash Acquisitions | -0.34 | -0.18 | -3.14 | 10.53 | -324.81 | -214.84 |
Divestitures | 291.26 | 629.75 | 172.2 | 60.16 | 52.44 | 14.61 |
Sale (Purchase) of Intangibles | -8.54 | -8.54 | -26.37 | -46.35 | -32.36 | -33.25 |
Investment in Securities | 7.94 | -20.71 | -18.46 | -71.28 | -61.58 | -65.06 |
Investing Cash Flow | -423.49 | -84.94 | -544.23 | -734.73 | -1,196 | -1,335 |
Short-Term Debt Issued | - | 84.81 | 65.34 | 717.09 | 1,804 | 794.83 |
Long-Term Debt Issued | - | 61.51 | 417.88 | 1,082 | 1,244 | 2,121 |
Total Debt Issued | 1,205 | 146.33 | 483.21 | 1,799 | 3,048 | 2,916 |
Short-Term Debt Repaid | - | -540.5 | -244.98 | -1,302 | -627.25 | -1,892 |
Long-Term Debt Repaid | - | -1,534 | -1,497 | -1,520 | -2,780 | -2,664 |
Total Debt Repaid | -2,179 | -2,075 | -1,742 | -2,822 | -3,407 | -4,556 |
Net Debt Issued (Repaid) | -974.04 | -1,928 | -1,259 | -1,023 | -358.9 | -1,640 |
Issuance of Common Stock | - | - | - | 20.15 | 6.51 | 12.65 |
Repurchase of Common Stock | -151.12 | - | - | - | - | -365.99 |
Common Dividends Paid | -422.52 | -349.16 | -328.62 | -395.56 | -392.46 | -351.17 |
Other Financing Activities | -612.33 | -291.89 | -270.75 | -218.91 | -279.54 | -319.69 |
Financing Cash Flow | -2,160 | -2,569 | -1,859 | -1,617 | -1,024 | -2,664 |
Foreign Exchange Rate Adjustments | -58.51 | 26.2 | -72.61 | -23.16 | 131.23 | -160.37 |
Net Cash Flow | -130.99 | -241.9 | 153.44 | -207.87 | 400.12 | 73.82 |
Free Cash Flow | 1,778 | 1,687 | 1,944 | 1,443 | 1,635 | 3,181 |
Free Cash Flow Growth | 13.64% | -13.24% | 34.70% | -11.73% | -48.60% | 120.58% |
Free Cash Flow Margin | 9.05% | 8.72% | 9.99% | 7.44% | 9.28% | 17.81% |
Free Cash Flow Per Share | 6.07 | 5.75 | 6.63 | 4.92 | 5.58 | 10.81 |
Cash Interest Paid | 365.44 | 381.23 | 394.54 | 350.68 | 341.63 | 379.99 |
Cash Income Tax Paid | 297.02 | 444.59 | 410.13 | 334.62 | 345.05 | 301.66 |
Levered Free Cash Flow | 2,149 | 2,031 | 1,312 | 1,023 | 1,697 | 2,356 |
Unlevered Free Cash Flow | 2,390 | 2,286 | 1,578 | 1,248 | 1,918 | 2,612 |
Change in Working Capital | 202.55 | 444.31 | 561.28 | -128.07 | -97.77 | 1,235 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.